Mitsubishi UFJ Trust & Banking Corp

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1462160 TOKYO, M0

Position in RXRX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$2,788,956

+$983,556 QoQ

Shares Held

908,455

+277.4% QoQ

Ownership

0.171%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Mitsubishi UFJ Trust & Banking Corp holds $300,915,992 across 16 Biotechnology names. RXRX ranks #11 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	166,903	$74,528,864
2	RPRX	Royalty Pharma plc	1,494,475	$71,689,965
3	REGN	Regeneron Pharmaceuticals, Inc.	50,755	$39,215,342
4	INCY	Incyte Corp	359,761	$33,860,704
5	ALNY	Alnylam Pharmaceuticals, Inc.	72,777	$24,079,724
6	MRNA	Moderna, Inc.	340,902	$17,317,821
7	INSM	INSMED Inc	84,184	$13,765,767
8	EXEL	Exelixis, Inc.	250,407	$10,739,956

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,788,956	908,455	+277.4%	Shares	Sole	2026-05-12
2024-06-30	$1,805,400	240,720	-11.0%	Shares	Sole	2024-08-08
2024-03-31	$2,695,489	270,360	-10.3%	Shares	Sole	2024-05-10
2023-12-31	$2,972,691	301,490	-13.7%	Shares	Sole	2024-02-09
2023-09-30	$2,673,445	349,470	-2.5%	Shares	Sole	2023-11-09
2023-06-30	$2,678,219	358,530	-2.4%	Shares	Sole	2023-08-08
2023-03-31	$2,450,491	367,390	0.0%	Shares	Sole	2023-05-10
2022-12-31	$2,832,576	367,390	0.0%	Shares	Sole	2023-02-10
2022-09-30	$3,909,029	367,390	-1.6%	Shares	Sole	2022-11-10
2022-06-30	$3,039,394	373,390	0.0%	Shares	Sole	2022-08-09
2022-03-31	$2,673,472	373,390	0.0%	Shares	Sole	2022-05-12
2021-12-31	$6,396,170	373,390	-6.3%	Shares	Sole	2022-02-09
2021-09-30	$9,167,644	398,420	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.